Insider filing · RNA
Michael F MacLean sold $1.3M of Avidity Biosciences (RNA)
Executed Aug 6 2025, disclosed Aug 15 2025, 9 days later, against a two-business-day limit.
Value, as filed
$1.3M
30,914 sh × $42.73
Executed
Aug 6 2025
the trade date, as filed
Disclosed
Aug 15 2025
9 days after the trade · past the deadline
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MM
Michael F MacLean
Chief Financial Officer
profile →
Michael F MacLean (Chief Financial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in RNA. The largest single filing was $329K of RNA (4,542 sh across 2 lots, as filed), executed Jan 21.
The name
RNA
RNA
RNA · 61 filings in 24 months
ticker →
Insider filings, newest first→
View the original filing at www.sec.gov→
Other filings by Michael F MacLean in RNA
RNASALE
Avidity Biosciences, Inc.
$329K4,542 sh across 2 lots
Exec Jan 21
Filed Jan 23 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. $143K
1,974 sh × $72.23
Exec Jan 7
Filed Jan 9 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. $246K
7,935 sh × $31.06
Exec Mar 20 2025
Filed Mar 21 2025 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. $364K
11,151 sh × $32.66
Exec Dec 18 2024
Filed Dec 19 2024 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. $4.8M
106,319 sh across 3 lots
Exec Nov 6 2024
Filed Nov 8 2024 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. $506K
11,510 sh × $44.00
Exec Sep 23 2024
Filed Sep 23 2024 · 5:30 PM ET